Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 2.1 Exhibit 2.1
- 2.2 Exhibit 2.2
- 2.3 Exhibit 2.3
- 2.4 Exhibit 2.4
- 2.5 Exhibit 2.5
- 2.6 Exhibit 2.6
- 2.7 Exhibit 2.7
- 3.1 Exhibit 3.1
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 5.1 Exhibit 5.1
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
- 99.2 Exhibit 99.2
- 99.4 Exhibit 99.4
- Download Excel data file
- View Excel data file
Associated filings
- 12 Feb 21 424B3 Prospectus supplement
- 11 Feb 21 EFFECT Notice of effectiveness
- 10 Feb 21 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Jan 21 S-4 Registration of securities issued in business combination transactions
CMMB similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Chemomab Ltd.:
We consent to the use of our report dated January 6, 2021, with respect to the balance sheets of Chemomab Ltd. as of December 31, 2019 and 2018, the related statements of operations, changes in equity, and cash flows for each of the years in the two-year period ended December 31, 2019, and the related notes, included herein and to the reference to our firm under the heading 'Experts' in the prospectus.
Our report refers to a change to the method of accounting for leases.
/s/ Somekh chaikin
Somekh Chaikin
Certified Public Accountants (lsr.)
Member Firm of KPMG International
Tel Aviv, Israel
January 13, 2021